Indeed, in this heavily pretreated, unselected patient population with lung adenocarcinoma, the median OS of GM.CD40L vaccine was comparable to results with chemotherapy and potentially comparable to some immune checkpoint inhibitors. This evidence concerns the gene CD40LG and lung adenocarcinoma.